NEPHROS (NEPH) Director Arthur Amron Acquires 43,295 Shares

What Happened

• Arthur H. Amron, a director of NEPHROS, acquired a total of 43,295 shares on September 14, 2026. That total includes a purchase of 22,710 shares at $3.95 each (total $89,705) and two additional transfers of 17,749 and 2,836 shares reported at $0.00 (in-kind/transfer transactions). These transactions are reported as acquisitions (code J) rather than open-market purchases or sales.

Key Details

• Transaction date: 2026-09-14; filing date (Form 4): 2026-09-16 (timely filing).
• Price/amounts: 22,710 shares @ $3.95 ($89,705); 17,749 and 2,836 shares reported at $0.00 (in-kind/transfer).
• Shares owned after transaction: Not specified in the excerpted filing.
• Notable footnotes:
  • F1: The $0.00 shares include an in-kind distribution from Wexford entities that did not involve purchase or sale.
  • F2: Some shares represent common stock held by Amron Holdings LLC.
  • F3: The $3.95 portion reflects a sale from Wexford entities to Amron Holdings, with proceeds distributed to underlying investors.
  • F4: Arthur Amron may be deemed the beneficial owner of shares held by Amron Holdings and has power to vote and dispose of those shares.
• Transaction code: J (other acquisition or disposition) — not a standard open-market buy code.

Context

• This is partly an outright purchase (22,710 shares for ~$89.7K) and partly internal transfers/in-kind distributions into entities tied to Mr. Amron. Transfers and in-kind distributions do not necessarily reflect new personal cash investment or market sentiment in the same way an open-market buy would. The filing indicates the shares are held or controlled via Amron Holdings, so the reported ownership is through that entity rather than a direct personal brokerage purchase.